These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9443712)

  • 101. Psychopathological symptoms and magnetic resonance imaging findings in multiple sclerosis.
    Reischies FM; Baum K; Nehrig C; Schörner W
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):676-8. PubMed ID: 8329501
    [No Abstract]   [Full Text] [Related]  

  • 102. Update on depression in neurologic illness: stroke, epilepsy, and multiple sclerosis.
    Sobel RM; Lotkowski S; Mandel S
    Curr Psychiatry Rep; 2005 Oct; 7(5):396-403. PubMed ID: 16216161
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The spectrum of depression in multiple sclerosis. An approach for clinical management.
    Schiffer RB
    Arch Neurol; 1987 Jun; 44(6):596-9. PubMed ID: 3579677
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Is there a personalized medicine for mood disorders?
    Bartova L; Berger A; Pezawas L
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S121-6. PubMed ID: 20957381
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Mood disorder in multiple sclerosis.
    Rao SM; Leo GJ
    Arch Neurol; 1988 Mar; 45(3):247-8. PubMed ID: 3341946
    [No Abstract]   [Full Text] [Related]  

  • 106. Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers.
    Mampay M; Flint MS; Sheridan GK
    Br J Pharmacol; 2021 Oct; 178(19):3977-3996. PubMed ID: 34029379
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Quantifying the Relationship Between Multiple Sclerosis Lesions and Depression.
    Tozlu C; Kuceyeski A
    Biol Psychiatry; 2024 Jun; 95(12):1058-1059. PubMed ID: 38811074
    [No Abstract]   [Full Text] [Related]  

  • 108. Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview.
    Vismara M; Girone N; Cirnigliaro G; Fasciana F; Vanzetto S; Ferrara L; Priori A; D'Addario C; Viganò C; Dell'Osso B
    Brain Sci; 2020 Aug; 10(8):. PubMed ID: 32824625
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Multiple sclerosis, inflammation in the brain, and mood.
    Karceski S
    Neurology; 2017 Sep; 89(13):e169-e171. PubMed ID: 28947591
    [No Abstract]   [Full Text] [Related]  

  • 110. Alterations in the Hypothalamic-Pituitary-Adrenal Axis as a Response to Experimental Autoimmune Encephalomyelitis in
    Milosevic A; Milosevic K; Zivkovic A; Lavrnja I; Savic D; Bjelobaba I; Janjic MM
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199407
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Gut-Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond.
    Zißler J; Rothhammer V; Linnerbauer M
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534341
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes.
    Chitnis T; Vandercappellen J; King M; Brichetto G
    Neurol Ther; 2022 Sep; 11(3):1043-1070. PubMed ID: 35680693
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic.
    Sparaco M; Miele G; Lavorgna L; Abbadessa G; Bonavita S
    Neurol Sci; 2022 May; 43(5):2935-2942. PubMed ID: 35092543
    [TBL] [Abstract][Full Text] [Related]  

  • 114. C-Reactive Protein Levels and Gadolinium-Enhancing Lesions Are Associated With the Degree of Depressive Symptoms in Newly Diagnosed Multiple Sclerosis.
    Yalachkov Y; Anschuetz V; Jakob J; Schaller-Paule MA; Schaefer JH; Reilaender A; Friedauer L; Behrens M; Foerch C
    Front Neurol; 2021; 12():719088. PubMed ID: 34764926
    [No Abstract]   [Full Text] [Related]  

  • 115. Exploring the roles of tryptophan metabolism in MS beyond neuroinflammation and neurodegeneration: A paradigm shift to neuropsychiatric symptoms.
    Tan LSY; Francis HM; Lim CK
    Brain Behav Immun Health; 2021 Mar; 12():100201. PubMed ID: 34589733
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Targeting the gut to treat multiple sclerosis.
    Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Molecular Examination of Differentially Expressed Genes in the Brains of Experimental Autoimmune Encephalomyelitis Mice Post Herceptin Treatment.
    Al-Ani M; Elemam NM; Hachim IY; Raju TK; Muhammad JS; Hachim MY; Bendardaf R; Maghazachi AA
    J Inflamm Res; 2021; 14():2601-2617. PubMed ID: 34168483
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.
    Ficiarà E; Munir Z; Boschi S; Caligiuri ME; Guiot C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923052
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities.
    Selvaraj K; Ravichandran S; Krishnan S; Radhakrishnan RK; Manickam N; Kandasamy M
    Reprod Sci; 2021 Oct; 28(10):2735-2742. PubMed ID: 33415647
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art.
    Silveira C; Guedes R; Maia D; Curral R; Coelho R
    Psychiatry Investig; 2019 Dec; 16(12):877-888. PubMed ID: 31805761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.